Rhythm Pharmaceuticals Down Nearly 10%, on Pace for Largest Percent Decrease Since May 2024 -- Data Talk
Dow Jones2026/11/03 18:39Rhythm Pharmaceuticals, Inc. (RYTM) is currently at $84.20, down $9.24 or 9.89%
--Would be lowest close since May 1, 2026, when it closed at $81.81
--On pace for largest percent decrease since May 7, 2024, when it fell 10.32%
--Currently down three of the past five days
--Down 21.34% year-to-date; on pace for worst year since 2021, when it fell 66.43%
--Down 28.41% from its all-time closing high of $117.62 on Dec. 11, 2025
--Down 19.80% from 52 weeks ago (Nov. 4, 2025), when it closed at $104.99
--Down 28.41% from its 52-week closing high of $117.62 on Dec. 11, 2025
--Up 11.05% from its 52-week closing low of $75.82 on March 27, 2026
--Traded as low as $81.58; lowest intraday level since May 4, 2026, when it hit $81.09
--Down 12.7% at today's intraday low; largest intraday percent decrease since April 9, 2025, when it fell as much as 13.63%
All data as of 1:36:51 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 03, 2026 13:39 ET (18:39 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Justin Sun Expects a Drop in Bitcoin — Details of the One-Hour Meeting Have Emerged

From "selling subscriptions" to "selling results": Adobe (ADBE.US) experiments with weekly billing for Acrobat, BTIG says growth sustainability remains to be verified
At the MAX conference held last week, Adobe unveiled new Agentic AI tools and previewed the upcoming local MCP (Model Context Protocol) integration. This feature will allow creators to directly access third-party agents within Photoshop, Illustrator, Premiere, and After Effects.

AI investment boom leads to job growth only at construction sites

